Liang Lu

Person

Hockessin, DE, US

People

Patents Grantslast 30 patents

Information Patent Grant
Substituted tricyclic compounds as FGFR inhibitors
- Patent number 11,840,534
- Issue date Dec 12, 2023
- Incyte Corporation
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
BRM targeting compounds and associated methods of use
- Patent number 11,702,423
- Issue date Jul 18, 2023
- Prelude Therapeutics Incorporated
- Hong Lin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds as immunomodulators
- Patent number 11,673,883
- Issue date Jun 13, 2023
- Incyte Corporation
- Liang Lu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CDK inhibitors and their use as pharmaceuticals
- Patent number 11,673,893
- Issue date Jun 13, 2023
- Prelude Therapeutics Incorporated
- Liang Lu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicyclic heterocycles as FGFR4 inhibitors
- Patent number 11,667,635
- Issue date Jun 6, 2023
- Incyte Corporation
- Liang Lu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic heterocycles as FGFR inhibitors
- Patent number 11,530,214
- Issue date Dec 20, 2022
- Incyte Holdings Corporation
- Liang Lu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted tricyclic compounds as FGFR inhibitors
- Patent number 11,053,246
- Issue date Jul 6, 2021
- Incyte Corporation
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicyclic heterocycles as FGFR4 inhibitors
- Patent number 11,014,923
- Issue date May 25, 2021
- Incyte Corporation
- Liang Lu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic heterocycles as FGFR4 inhibitors
- Patent number 10,851,105
- Issue date Dec 1, 2020
- Incyte Corporation
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Immunomodulator compounds and methods of use
- Patent number 10,806,785
- Issue date Oct 20, 2020
- Incyte Corporation
- Liang Lu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicyclic heterocycles as FGFR4 inhibitors
- Patent number 10,738,048
- Issue date Aug 11, 2020
- Incyte Corporation
- Liang Lu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazopyridines and imidazopyrazines as LSD1 inhibitors
- Patent number 10,640,503
- Issue date May 5, 2020
- Incyte Corporation
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors
- Patent number 10,556,908
- Issue date Feb 11, 2020
- Incyte Corporation
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic heterocycles as FGFR inhibitors
- Patent number 10,450,313
- Issue date Oct 22, 2019
- Incyte Holdings Corporation
- Liang Lu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicyclic heterocycles as FGFR4 inhibitors
- Patent number 10,214,528
- Issue date Feb 26, 2019
- Incyte Corporation
- Liang Lu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted tricyclic compounds as FGFR inhibitors
- Patent number 10,131,667
- Issue date Nov 20, 2018
- Incyte Corporation
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors
- Patent number 10,112,950
- Issue date Oct 30, 2018
- Incyte Corporation
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazopyridines and imidazopyrazines as LSD1 inhibitors
- Patent number 10,047,086
- Issue date Aug 14, 2018
- Incyte Corporation
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic heterocycles as FGFR inhibitors
- Patent number 10,040,790
- Issue date Aug 7, 2018
- Incyte Holdings Corporation
- Yaping Sun
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic heterocycles as FGFR4 inhibitors
- Patent number 10,016,438
- Issue date Jul 10, 2018
- Incyte Corporation
- Liang Lu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicyclic heterocycles as FGFR4 inhibitors
- Patent number 9,890,156
- Issue date Feb 13, 2018
- Incyte Corporation
- Liang Lu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic heterocycles as FGFR4 inhibitors
- Patent number 9,801,889
- Issue date Oct 31, 2017
- Incyte Corporation
- Liang Lu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
- Patent number 9,745,311
- Issue date Aug 29, 2017
- Incyte Corporation
- Liang Lu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic heterocycles as FGFR4 inhibitors
- Patent number 9,708,318
- Issue date Jul 18, 2017
- Incyte Corporation
- Liang Lu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors
- Patent number 9,695,180
- Issue date Jul 4, 2017
- Incyte Corporation
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted imidazo[1,5-α]pyridines and imidazo[1,5-α]pyrazines as...
- Patent number 9,695,168
- Issue date Jul 4, 2017
- Incyte Corporation
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted tricyclic compounds as FGFR inhibitors
- Patent number 9,611,267
- Issue date Apr 4, 2017
- Incyte Holdings Corporation
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic heterocycles as FGFR4 inhibitors
- Patent number 9,580,423
- Issue date Feb 28, 2017
- Incyte Corporation
- Liang Lu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic heterocycles as FGFR inhibitors
- Patent number 9,533,984
- Issue date Jan 3, 2017
- Incyte Holdings Corporation
- Yaping Sun
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
CRYSTALLINE FORMS OF A CDK9 INHIBITOR AND USES THEREOF
- Publication number 20250011298
- Publication date Jan 9, 2025
- Prelude Therapeutics Incorporated
- Ganfeng CAO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BRM Targeting Compounds And Associated Methods Of Use
- Publication number 20240336612
- Publication date Oct 10, 2024
- Prelude Therapeutics Incorporated
- Liang Lu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED TRICYCLIC COMPOUNDS AS FGFR INHIBITORS
- Publication number 20240246974
- Publication date Jul 25, 2024
- INCYTE CORPORATION
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BRM Targeting Compounds and Associated Methods of Use
- Publication number 20240190886
- Publication date Jun 13, 2024
- Prelude Therapeutics Incorporated
- Corey Howard Basch
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE
- Publication number 20240018158
- Publication date Jan 18, 2024
- Prelude Therapeutics Incorporated
- Hong Lin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BRM Targeting Compounds And Associated Methods Of Use
- Publication number 20230365576
- Publication date Nov 16, 2023
- Prelude Therapeutics Incorporated
- John A. Rose
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heterocycle CDK Inhibitors And Their Use Thereof
- Publication number 20230265083
- Publication date Aug 24, 2023
- Prelude Therapeutics Incorporated
- Liang Lu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CDK Inhibitors And Their Use As Pharmaceuticals
- Publication number 20230242543
- Publication date Aug 3, 2023
- Prelude Therapeutics Incorporated
- Liang Lu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20230226062
- Publication date Jul 20, 2023
- INCYTE CORPORATION
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CDK Inhibitors And Their Use As Pharmaceuticals
- Publication number 20230144528
- Publication date May 11, 2023
- Prelude Therapeutics Incorporated
- Liang Lu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BRM Targeting Compounds And Associated Methods Of Use
- Publication number 20230083376
- Publication date Mar 16, 2023
- Prelude Therapeutics Incorporated
- Liang Lu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CDK Inhibitors And Their Use As Pharmaceuticals
- Publication number 20220324830
- Publication date Oct 13, 2022
- Prelude Therapeutics, Incorporated
- Liang Lu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20220194931
- Publication date Jun 23, 2022
- INCYTE CORPORATION
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE
- Publication number 20220033409
- Publication date Feb 3, 2022
- Prelude Therapeutics, Incorporated
- Hong Lin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BICYCLIC HETEROCYCLES AS FGFR4 INHIBITORS
- Publication number 20220009921
- Publication date Jan 13, 2022
- INCYTE CORPORATION
- Liang Lu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BICYCLIC HETEROCYCLES AS FGFR INHIBITORS
- Publication number 20210395246
- Publication date Dec 23, 2021
- INCYTE CORPORATION
- Yaping Sun
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED TRICYCLIC COMPOUNDS AS FGFR INHIBITORS
- Publication number 20210380587
- Publication date Dec 9, 2021
- INCYTE CORPORATION
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20210107900
- Publication date Apr 15, 2021
- INCYTE CORPORATION
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS
- Publication number 20210070761
- Publication date Mar 11, 2021
- Prelude Therapeutics Incorporated
- Liang Lu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20210017164
- Publication date Jan 21, 2021
- Incyte Corporation
- Liang Lu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMMUNOMODULATOR COMPOUNDS AND METHODS OF USE
- Publication number 20200397893
- Publication date Dec 24, 2020
- INCYTE CORPORATION
- Phillip C. Liu
- G01 - MEASURING TESTING
Information Patent Application
BICYCLIC HETEROCYCLES AS FGFR4 INHIBITORS
- Publication number 20200399267
- Publication date Dec 24, 2020
- INCYTE CORPORATION
- Liang Lu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED TRICYCLIC COMPOUNDS AS FGFR INHIBITORS
- Publication number 20200377504
- Publication date Dec 3, 2020
- INCYTE CORPORATION
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BICYCLIC HETEROCYCLES AS FGFR4 INHIBITORS
- Publication number 20200306256
- Publication date Oct 1, 2020
- INCYTE CORPORATION
- Liang Lu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20200181126
- Publication date Jun 11, 2020
- INCYTE CORPORATION
- Liang Lu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BICYCLIC HETEROCYCLES AS FGFR INHIBITORS
- Publication number 20200095244
- Publication date Mar 26, 2020
- INCYTE CORPORATION
- Yaping Sun
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BICYCLIC HETEROCYCLES AS FGFR4 INHIBITORS
- Publication number 20190284187
- Publication date Sep 19, 2019
- Incyte Corporation
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BICYCLIC HETEROCYCLES AS FGFR4 INHIBITORS
- Publication number 20190269693
- Publication date Sep 5, 2019
- INCYTE CORPORATION
- Liang Lu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BICYCLIC HETEROCYCLES AS FGFR4 INHIBITORS
- Publication number 20190241560
- Publication date Aug 8, 2019
- INCYTE CORPORATION
- Liang Lu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20190225601
- Publication date Jul 25, 2019
- INCYTE CORPORATION
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY

Person

Patents Grantslast 30 patents

Substituted tricyclic compounds as FGFR inhibitors

BRM targeting compounds and associated methods of use

Heterocyclic compounds as immunomodulators

CDK inhibitors and their use as pharmaceuticals

Bicyclic heterocycles as FGFR4 inhibitors

Bicyclic heterocycles as FGFR inhibitors

Substituted tricyclic compounds as FGFR inhibitors

Bicyclic heterocycles as FGFR4 inhibitors

Bicyclic heterocycles as FGFR4 inhibitors

Immunomodulator compounds and methods of use

Bicyclic heterocycles as FGFR4 inhibitors

Imidazopyridines and imidazopyrazines as LSD1 inhibitors

Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors

Bicyclic heterocycles as FGFR inhibitors

Bicyclic heterocycles as FGFR4 inhibitors

Substituted tricyclic compounds as FGFR inhibitors

Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors

Imidazopyridines and imidazopyrazines as LSD1 inhibitors

Bicyclic heterocycles as FGFR inhibitors

Bicyclic heterocycles as FGFR4 inhibitors

Bicyclic heterocycles as FGFR4 inhibitors

Bicyclic heterocycles as FGFR4 inhibitors

Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors

Bicyclic heterocycles as FGFR4 inhibitors

Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors

Substituted imidazo[1,5-α]pyridines and imidazo[1,5-α]pyrazines as...

Substituted tricyclic compounds as FGFR inhibitors

Bicyclic heterocycles as FGFR4 inhibitors

Bicyclic heterocycles as FGFR inhibitors

Patents Applicationslast 30 patents

CRYSTALLINE FORMS OF A CDK9 INHIBITOR AND USES THEREOF

BRM Targeting Compounds And Associated Methods Of Use

SUBSTITUTED TRICYCLIC COMPOUNDS AS FGFR INHIBITORS

BRM Targeting Compounds and Associated Methods of Use

BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE

BRM Targeting Compounds And Associated Methods Of Use

Heterocycle CDK Inhibitors And Their Use Thereof

CDK Inhibitors And Their Use As Pharmaceuticals

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

CDK Inhibitors And Their Use As Pharmaceuticals

BRM Targeting Compounds And Associated Methods Of Use

CDK Inhibitors And Their Use As Pharmaceuticals

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE

BICYCLIC HETEROCYCLES AS FGFR4 INHIBITORS

BICYCLIC HETEROCYCLES AS FGFR INHIBITORS

SUBSTITUTED TRICYCLIC COMPOUNDS AS FGFR INHIBITORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

IMMUNOMODULATOR COMPOUNDS AND METHODS OF USE

BICYCLIC HETEROCYCLES AS FGFR4 INHIBITORS

SUBSTITUTED TRICYCLIC COMPOUNDS AS FGFR INHIBITORS

BICYCLIC HETEROCYCLES AS FGFR4 INHIBITORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

BICYCLIC HETEROCYCLES AS FGFR INHIBITORS

BICYCLIC HETEROCYCLES AS FGFR4 INHIBITORS

BICYCLIC HETEROCYCLES AS FGFR4 INHIBITORS

BICYCLIC HETEROCYCLES AS FGFR4 INHIBITORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS